AI assistant
STAAR SURGICAL CO — Director's Dealing 2021
Sep 3, 2021
31996_dirs_2021-09-03_aba5cbd5-773d-481f-aadb-22e60e8b065a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-09-01
Reporting Person: Blickensdoerfer Hans-Martin (Sr. VP, Comm. Ops, China)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-01 | Common Stock | S | 8621 | $157.61 | Disposed | 99760 | Direct |
| 2021-09-01 | Common Stock | M | 17573 | $16.15 | Acquired | 117333 | Direct |
| 2021-09-01 | Common Stock | S | 17573 | $157.61 | Disposed | 99760 | Direct |
| 2021-09-02 | Common Stock | S | 11038 | $157.50 | Disposed | 88722 | Direct |
| 2021-09-02 | Common Stock | M | 871 | $16.15 | Acquired | 89593 | Direct |
| 2021-09-02 | Common Stock | M | 13484 | $29.80 | Acquired | 103077 | Direct |
| 2021-09-02 | Common Stock | M | 2988 | $35.98 | Acquired | 106065 | Direct |
| 2021-09-02 | Common Stock | S | 17343 | $157.50 | Disposed | 88722 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-01 | Common Stock Options | $16.15 | M | 17573 | Disposed | 2028-03-14 | Common Stock (17573) | Direct |
| 2021-09-02 | Common Stock Options | $16.15 | M | 871 | Disposed | 2028-03-14 | Common Stock (871) | Direct |
| 2021-09-02 | Common Stock Options | $29.80 | M | 13484 | Disposed | 2028-06-13 | Common Stock (13484) | Direct |
| 2021-09-02 | Common Stock Options | $35.98 | M | 2988 | Disposed | 2029-03-13 | Common Stock (2988) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.56, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.72, inclusive.
F5: The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.